Provisional Application Toolkit: Invention Capture Templates, Written Description Audits, and Conversion Calendars

Summary. This toolkit collects the working papers that a provisional patent application runs on, each introduced by its purpose, its owner, and when to use it, and each followed by drafting commentary tied to the governing statute, rule, or case. The early templates cover a pre-pitch disclosure policy, an invention capture interview form, an inventorship contribution map, and a short-form present assignment. The drafting templates are a specification skeleton and a written description audit worksheet that tests every feature the business may claim against the text and figures. The filing templates cover cover sheet data, entity status, and a filing receipt review log, and the conversion templates are an improvement log, a conversion and priority calendar, a month-nine decision memo, a priority map, and an inventor declaration packet. A running example follows a wearable-sensor startup through each form, and the toolkit closes with a deadline tracker and practical notes.

A provisional application is a single filing, but it depends on a dozen smaller documents that nobody at the Patent Office ever sees: the policy that kept the invention secret until filing, the interview notes that captured the alternatives, the assignment that put title in the company, the audit that proved the text supports the claims, and the calendar that got the nonprovisional filed in month eleven. When a priority challenge comes years later, those documents are the evidence. This toolkit supplies them.

The short answer

• Control disclosure first. Template 1 is a one-page policy; adopt it on day one.
• Capture before drafting. Templates 2 and 3 produce the alternatives, ranges, and contribution records that support broad claims and correct inventorship.
• Paper title. Template 4 is a present assignment for anyone whose agreement is missing or uses future-tense language.
• Audit the draft. Template 6 tests every claimable feature against specific paragraphs and figures. A feature without a citation is unsupported.
• Calendar the year. Template 11 sets month nine for decisions, month eleven for filing, and the foreign deadline separately.
• Map priority at conversion. Template 13 is the patentee's answer to every future challenge, and the challenger's starting point.

How to use this toolkit

Each template states its purpose, its owner, and when to use it, then gives the template and drafting commentary. Bracketed text in capitals is to be filled in. Use one numbering system across all forms: F- for features (F-1, F-2), P- for provisionals (P1, P2), and C- for claims, so the capture form, audit worksheet, and priority map all point to the same things.

The doctrine is in Provisional Patent Applications: What They Protect, What They Do Not, and How to Keep the Priority Date; the step-by-step narrative is in Preparing and Filing a Provisional Patent Application: A Practical Guide; the task list is the Provisional Patent Application Checklist: A Practical Checklist.

Running example. Halden Grove Labs, Inc., a Delaware corporation based in Raleigh, North Carolina, makes a disposable skin patch that measures lactate in sweat for endurance athletes and sends readings to a phone. Its founders are Dr. Imani Castellanos (CEO, electrochemistry) and Felix Oduya (firmware). A contract materials chemist in Oslo, Sunniva Berg, developed the hydrogel that wicks sweat to the electrode. Halden Grove has been invited to a sports-technology accelerator demo day in seven weeks.

Template 1: Pre-pitch disclosure policy

Purpose: keep the invention out of the public domain until a provisional covering it is on file. Owner: the founder or general counsel. When to use: adopt on day one; circulate to everyone who will present, sell, or post.

[COMPANY] PRE-FILING DISCLOSURE POLICY
Effective [DATE]. Applies to: all employees, contractors, and advisors.

1. Covered information. Technical details of [PROJECT NAME], including
   structure, materials, methods, algorithms, test data, and roadmaps.

2. Before a patent application is on file, Covered Information may be shared
   outside [COMPANY] only:
   (a) under a signed nondisclosure agreement approved by [COUNSEL]; and
   (b) to the minimum extent needed for the business purpose.

3. Public materials. No abstract, poster, talk, deck, video, website text,
   social post, app listing, code release, or grant report that describes
   Covered Information may be submitted or published until [COUNSEL]
   confirms in writing that a filing covering it is on file.

4. Commercial activity. No quote, price, offer, purchase order, pilot
   agreement, or sale involving products embodying Covered Information
   until [COUNSEL] confirms filing.

5. AI tools. Covered Information may not be entered into any AI tool other
   than [APPROVED TOOLS] configured under [COMPANY]'s AI use policy.

6. Investors. Pitch materials shown before filing describe the problem,
   market, team, and results, not mechanisms. Data rooms containing Covered
   Information require access controls and click-through confidentiality.

7. Questions and exceptions: [COUNSEL NAME, EMAIL]. Exceptions in writing only.

Drafting commentary. Each clause answers a specific source of prior art under 35 U.S.C. § 102(a)(1). Clause 3 covers printed publications, which include posters displayed briefly at meetings, In re Klopfenstein, 380 F.3d 1345 (Fed. Cir. 2004). Clause 4 addresses the on-sale bar, which requires only a commercial offer of an invention ready for patenting, Pfaff v. Wells Electronics, Inc., 525 U.S. 55 (1998), and which a confidential sale can trigger, Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., 586 U.S. 123 (2019). Clause 5 matters for both patents and trade secrets: whether input to a public AI tool is a disclosure depends on the tool's terms, and loose use undermines the "reasonable measures" that 18 U.S.C. § 1839(3) requires. Pair the policy with the clauses in AI Confidentiality Toolkit: Acceptable Use Policies, Vendor Term Reviews, and Incident Playbooks. NDA forms are discussed in Drafting Enforceable Non-Disclosure Agreements for Technology Transactions.

Halden Grove sample. The accelerator asks for a one-paragraph product description for its website three weeks before demo day. Under clause 3, the description reads: "A disposable patch that tracks sweat lactate in real time." It says nothing about the hydrogel or the electrode.

Template 2: Invention capture interview form

Purpose: record, feature by feature, everything the provisional must describe to support later claims. Owner: patent counsel, interviewing each inventor. When to use: week one; repeat for each improvement during the year.

Drafting commentary. The form is built around the written description and enablement requirements of 35 U.S.C. § 112(a). "Alternatives" and "design-arounds" exist because an obvious variant of a described embodiment is not itself described, Lockwood v. American Airlines, Inc., 107 F.3d 1565 (Fed. Cir. 1997). "Operating ranges" and "failed experiments" support range claims and their limits, and give the guidance that keeps experimentation from being undue under In re Wands, 858 F.2d 731 (Fed. Cir. 1988). "Conceived by" and "date" feed Template 3. "Where conceived" feeds the foreign filing license analysis under 35 U.S.C. § 184. Inventors can prepare in advance using How to Prepare an Invention Disclosure for Your Patent Attorney.

Halden Grove sample (F-2, hydrogel wicking layer). Components: a polyacrylamide-alginate hydrogel, 150 to 400 microns thick (preferred 200 to 250), with a glycerol content range. Alternatives: a cellulose wick (tested; slower), a microfluidic channel (planned for version two). Failed: gels above 500 microns delayed readings by over four minutes. Design-arounds: other hydrophilic polymers; a paper wick with a hydrogel interface. Conceived by Sunniva Berg in Oslo, with Imani Castellanos specifying the response-time target.

Template 3: Inventorship contribution map

Purpose: track who contributed to the conception of each feature, so the cover sheet and later declarations name the right people. Owner: patent counsel. When to use: start in week one; update when claims are drafted and again at conversion.

Drafting commentary. Inventorship is decided claim by claim, and a person who contributes to the conception of a single claim is a joint inventor, 35 U.S.C. § 116(a); Ethicon, Inc. v. United States Surgical Corp., 135 F.3d 1456 (Fed. Cir. 1998). The two middle columns track the factors of Pannu v. Iolab Corp., 155 F.3d 1344 (Fed. Cir. 1998). Conception, not reduction to practice, is what counts, Burroughs Wellcome Co. v. Barr Laboratories, Inc., 40 F.3d 1223 (Fed. Cir. 1994). Only natural persons qualify, Thaler v. Vidal, 43 F.4th 1207 (Fed. Cir. 2022); if an AI tool generated candidate designs, record the human contribution in the third column. Because the provisional has no formal claims, use features as proxies at filing, then redo the map against the nonprovisional's claims. Errors can be corrected under 37 C.F.R. § 1.48 during prosecution and 35 U.S.C. § 256 after issuance. The provisional and the nonprovisional must share at least one inventor under 35 U.S.C. § 119(e)(1). For AI-assisted work, see AI-Generated Inventions: Who Owns What the Machine Creates?.

Halden Grove sample. F-1 (electrode with enzyme layer): Castellanos. F-2 (hydrogel): Berg, with Castellanos's response-time target noted as a goal, not a conception of the gel. F-3 (temperature-compensation firmware): Oduya. The final column flags Berg: her consulting agreement says she "shall assign upon request."

Template 4: Short-form present assignment of invention

Purpose: move legal title to the company before filing from anyone whose agreement is missing, ambiguous, or future-tense. Owner: corporate counsel. When to use: before filing; again for each follow-up provisional if the contributor's agreement does not already cover it.

ASSIGNMENT OF INVENTION

For good and valuable consideration, the receipt of which is acknowledged,
[ASSIGNOR NAME], residing at [CITY, COUNTRY] ("Assignor"), hereby assigns
to [COMPANY LEGAL NAME], a [STATE] [ENTITY TYPE] ("Assignee"), Assignor's
entire right, title, and interest in and to:

(a) the inventions and improvements described in [DESCRIPTION, OR "the
    document titled ___ dated ___, attached as Exhibit A"], and all
    inventions conceived by Assignor, alone or with others, relating to
    [FIELD] during [PERIOD] (the "Inventions");
(b) every patent application describing or claiming the Inventions,
    including provisional application No. [NUMBER, IF FILED], and all
    nonprovisional, continuation, divisional, continuation-in-part, and
    foreign and international applications claiming priority to any of them;
(c) all patents issuing on any of them, and all reissues, reexamination
    certificates, and extensions; and
(d) all rights of priority under the Paris Convention and otherwise, and all
    rights to sue for past, present, and future infringement.

Assignor will sign further documents reasonably requested to perfect,
record, or enforce these rights, including declarations under 35 U.S.C.
115, at Assignee's expense. Assignor authorizes the Director of the USPTO
and any foreign office to issue patents to Assignee.

Signed: ____________________  Date: __________  [NOTARIZATION OR WITNESS IF
REQUIRED FOR FOREIGN USE]

Drafting commentary. "Hereby assigns" is the operative phrase. A present assignment of future rights transfers legal title automatically once the invention exists, FilmTec Corp. v. Allied-Signal Inc., 939 F.2d 1568 (Fed. Cir. 1991); a promise to assign leaves title with the inventor, which is why Stanford lost its patents in Board of Trustees of Leland Stanford Junior University v. Roche Molecular Systems, Inc., 563 U.S. 776 (2011), and why policy language stating that inventions "shall be the property" of an institution was not enough in Omni MedSci, Inc. v. Apple Inc., 7 F.4th 1148 (Fed. Cir. 2021). Clause (d) captures the Paris priority right, which some foreign offices treat as separately transferable. Record the assignment under 35 U.S.C. § 261, which protects the assignee against a later purchaser without notice if recorded within three months or before the later purchase. For a fuller set of founder and contractor clauses, see Brand Ownership Toolkit: Assignment Agreements, Founder IP Clauses, and Ownership Evidence Files and Employee Invention Assignment Agreements: Drafting for Enforceability Across Jurisdictions. Where the assignor works under foreign law, check local employee-invention and contractor rules before relying on a U.S.-style form.

Halden Grove sample. Sunniva Berg signs the form in week one, with Exhibit A describing the hydrogel work. Counsel asks Norwegian counsel to confirm that nothing in Norwegian law limits a contractor's assignment of this kind.

Template 5: Specification skeleton

Purpose: give the drafter a structure that produces a nonprovisional-quality disclosure. Owner: patent counsel. When to use: weeks one through three, populated from Templates 2 and 3.

TITLE: [PLAIN NAME OF THE INVENTION]

FIELD
[ONE TO TWO SENTENCES.]

BACKGROUND
[SHORT, FACTUAL DESCRIPTION OF THE PROBLEM. NO CHARACTERIZATION OF ANY
REFERENCE AS "CLOSEST" OR ANY FEATURE AS "WELL KNOWN" UNLESS INTENDED.]

SUMMARY
[BROADEST STATEMENT OF THE INVENTION, IN CLAIM-LIKE SENTENCES.]
[INTERMEDIATE STATEMENTS ADDING KEY FEATURES F-1 ... F-N.]
[NARROW STATEMENTS ADDING PREFERRED RANGES AND COMBINATIONS.]

BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is ... [ONE SENTENCE PER FIGURE.]

DETAILED DESCRIPTION
1. Overview of the system [REFERENCE NUMERALS].
2. For each feature F-#:
   2.1 Structure (components, materials, connections, dimensions).
   2.2 Operation (steps, order, timing, control logic).
   2.3 Ranges (broad / preferred / example).
   2.4 Alternatives ("In some embodiments ... In other embodiments ...").
   2.5 Failure limits and why.
3. Methods of making.
4. Methods of use.
5. Software and data (architecture, data flow, model structure, training data,
   preprocessing, thresholds, how outputs control the system). [IF
   APPLICABLE]
6. Combinations of features and the system-level embodiments.
7. Best mode (the preferred configuration as of filing).

EXAMPLES
[EXPERIMENTS, CONDITIONS, RESULTS, INCLUDING NEGATIVE RESULTS.]

DEFINITIONS
[TERMS OF ART AND COINED TERMS.]

DRAFT CLAIMS [OPTIONAL BUT RECOMMENDED]
1. [BROAD APPARATUS CLAIM]
...
[METHOD CLAIM] [SYSTEM CLAIM] [DEPENDENTS FOR EACH F-# AND RANGE]

Drafting commentary. A provisional needs only a specification complying with § 112(a) and drawings where necessary, under 35 U.S.C. § 111(b) and 35 U.S.C. § 113. But the nonprovisional's claims get the provisional's date only if the provisional describes and enables the claimed invention, New Railhead Manufacturing, L.L.C. v. Vermeer Manufacturing Co., 298 F.3d 1290 (Fed. Cir. 2002). Section 2.4 (alternatives) and section 6 (combinations) are where most thin provisionals fail. Section 5 matters for eligibility as well as support; see Patent Subject-Matter Eligibility After Alice: A Practical Checklist. Section 7 is not part of the priority test under § 119(e)(1), but § 112(a) still requires it. Reading How to Read a Patent: Claims, Specification, and Prosecution History helps non-lawyer drafters understand how each section will later be used.

Template 6: Written description audit worksheet

Purpose: test, before filing and again at conversion, whether the provisional supports every feature the business may want to claim. Owner: patent counsel, with the inventors. When to use: on the final draft before filing; on the filed provisional before drafting the nonprovisional's claims.

Scoring rule: any row with no paragraph citation, "result only," or "not enabled" is a gap. Before filing, close the gap in the draft. After filing, close it with a follow-up provisional (Template 10) or accept that claims relying on it will take a later date.

Drafting commentary. Each column tracks a line of authority. "Structure or only result" follows University of Rochester v. G.D. Searle & Co., 358 F.3d 916 (Fed. Cir. 2004), where describing a desired result without a means of achieving it failed. "Alternatives described" responds to Lockwood and to the requirement, confirmed en banc in Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., 598 F.3d 1336 (Fed. Cir. 2010), that the disclosure show possession of what is claimed, including a genus through representative species or common structural features. "Enabled across claimed scope" applies Amgen Inc. v. Sanofi, 598 U.S. 594 (2023). "Supporting figures" matters because drawings can supply support, and their absence was decisive in New Railhead. Run the audit with the inventors present; they will see gaps the drafter cannot.

Halden Grove sample.

The audit sends the draft back for two days. The microfluidic channel gets three paragraphs and a figure; the analyte genus gets a second worked example and a paragraph explaining what the enzyme layer requires.

Template 7: Cover sheet data form

Purpose: collect and verify everything the provisional cover sheet must state. Owner: paralegal, verified by counsel. When to use: before filing.

Drafting commentary. The cover sheet requirements are in 37 C.F.R. § 1.51(c)(1); the filing date is set by receipt of the specification and drawings under § 1.53(c), and a missing cover sheet or fee can be supplied later with a surcharge. An assignee may be the applicant under 35 U.S.C. § 118. The government interest line implements the Bayh-Dole statement required by 35 U.S.C. § 202(c)(6); see University Technology Transfer and Bayh-Dole: Who Owns Federally Funded Inventions. Use the same spelling of each name that will appear on the nonprovisional and foreign filings. The Office's provisional cover sheet form or an application data sheet may be used.

Template 8: Entity status worksheet

Purpose: determine and document small or micro entity status. Owner: paralegal, reviewed by counsel. When to use: before filing and before every later fee payment.

Drafting commentary. Small entity status is defined in 37 C.F.R. § 1.27 and micro status in 35 U.S.C. § 123 and 37 C.F.R. § 1.29. The 60 percent small entity reduction is in 35 U.S.C. § 41(h)(1); the 80 percent micro entity reduction comes from section 10(b) of the America Invents Act, as amended in 2022. Errors in good faith are corrected by paying the deficiency under § 1.28(c); a false assertion is another matter, because the 2022 amendments added 35 U.S.C. § 41(j), which imposes a fine of at least three times the underpayment unless the entity shows good faith. Check the published income limit for the relevant year and the current fee schedule; fees were last broadly adjusted effective January 19, 2025.

Halden Grove sample. Fourteen employees, no licenses, but a supply agreement with a large sporting-goods company includes a right of first negotiation for a license. Counsel reads it as not yet an "obligation" to license and claims small entity status, records the reasoning in the worksheet, and diaries a re-check before the nonprovisional fees.

Template 9: Filing receipt review log

Purpose: confirm that the filing receipt matches what was filed, and catch a missing foreign filing license. Owner: docketing. When to use: on the electronic acknowledgment and again on the official filing receipt.

Drafting commentary. The foreign filing license requirement is in 35 U.S.C. § 184 and 37 C.F.R. part 5. A foreign filing without a required license can bar the U.S. patent under 35 U.S.C. § 185, subject to retroactive licensing for errors made without deceptive intent. Saving a hashed copy of what was filed lets counsel later prove exactly what the provisional said, which matters when the file wrapper copy is a poor scan.

Halden Grove sample. The receipt grants a foreign filing license. Because part of the invention (the hydrogel) was conceived in Norway, counsel also asks Norwegian counsel whether Norway imposes any filing or security-review requirement before a foreign application claiming that subject matter is filed, and records the answer.

Template 10: Improvement log and follow-up provisional trigger

Purpose: catch improvements made during the provisional year and file them before they are disclosed. Owner: product lead, reviewed monthly with counsel. When to use: monthly from filing to conversion.

Drafting commentary. A provisional cannot be amended to add matter, and a nonprovisional's added content gets only the nonprovisional's date under 35 U.S.C. § 119(e)(1). A follow-up provisional gives each improvement its own date. A single nonprovisional can claim several provisionals, provided it is filed within twelve months of each. The "planned disclosure date" column links this log to Template 1: any improvement scheduled for a public event needs a filing first.

Template 11: Conversion and priority calendar

Purpose: put every date that the provisional starts on the docket at filing. Owner: docketing. When to use: on the day of filing; update for each follow-up provisional.

Drafting commentary. The twelve-month deadline comes from 35 U.S.C. § 119(e), with the weekend and holiday rule in 35 U.S.C. § 21(b). The abandonment rule in § 111(b)(5) means no revival after twelve months; restoration under 37 C.F.R. § 1.78(b) is a petition for unintentional delay, not an extension, and does not restore foreign priority. The PCT route runs under 35 U.S.C. § 365 and national-stage entry under 35 U.S.C. § 371. Term runs from the nonprovisional filing date, 35 U.S.C. § 154(a)(2). For portfolio-wide calendars, see Global Patent Portfolio Toolkit: Filing Calendars, National Phase Instructions, and Cost Models.

Template 12: Month-nine decision memo

Purpose: get a documented business decision on each provisional in time to act on it. Owner: counsel, for the CEO or board. When to use: month nine.

PRIVILEGED AND CONFIDENTIAL: ATTORNEY-CLIENT COMMUNICATION

To: [DECISION MAKER]   From: [COUNSEL]   Date: [DATE]
Re: Provisional application(s) [P1, P2 ...]; conversion deadline [DATE]

1. What is on file. [P#: FILED; FEATURES COVERED; AUDIT GAPS REMAINING]
2. What has changed. [IMPROVEMENTS (TEMPLATE 10); PRODUCT DIRECTION;
   COMPETITOR ACTIVITY; SEARCH RESULTS]
3. Options for each provisional.
   (a) Convert to U.S. nonprovisional [SCOPE; COST RANGE]
   (b) File PCT [COST RANGE; NATIONAL PHASE AT 30 MONTHS; LIKELY COUNTRIES]
   (c) Direct foreign filings [COUNTRIES; COST RANGE]
   (d) Let lapse and keep as trade secret [WHAT REMAINS SECRET; RISKS]
4. Recommendation. [OPTION; REASONS]
5. Deadlines. [FROM TEMPLATE 11]
6. Decisions needed by [DATE]. [LIST]

Drafting commentary. Option (d) is real because a provisional never publishes on its own, 35 U.S.C. § 122, and federal law has long allowed trade secret protection to coexist with the patent system, Kewanee Oil Co. v. Bicron Corp., 416 U.S. 470 (1974). But a feature visible in the product will not stay secret, and once it is public without patent protection, anyone may copy it, Bonito Boats, Inc. v. Thunder Craft Boats, Inc., 489 U.S. 141 (1989). If the decision is to convert without foreign filing, address the nonpublication request in the memo. For trade secret program design, see Trade Secret Protection Toolkit: Building and Defending a Confidentiality Program.

Template 13: Priority map

Purpose: document, for each claim of the nonprovisional, which provisional supports it and where. Owner: patent counsel. When to use: at conversion; update with each claim amendment during prosecution.

Drafting commentary. Priority is decided claim by claim, and there is no presumption that a claim is entitled to an earlier date. When a challenger shows intervening art, the patentee must come forward with evidence of entitlement, PowerOasis, Inc. v. T-Mobile USA, Inc., 522 F.3d 1299 (Fed. Cir. 2008). This chart is that evidence, prepared while the inventors are available. A claim's effective filing date is defined in 35 U.S.C. § 100(i). The same chart, built by the other side, is the core of a priority challenge; when a challenger relies on a reference's provisional date, it may need to chart the reference's own claims against that provisional, Dynamic Drinkware, LLC v. National Graphics, Inc., 800 F.3d 1375 (Fed. Cir. 2015). Invalidity charts for that use are in the Prior Art Toolkit: Search Protocols, Invalidity Charts, and On-Sale Bar Investigations.

Halden Grove sample. Claims 1 to 12 map to P1; claims 13 to 16 (a replaceable electrode cartridge Felix Oduya conceived in month five, logged in Template 10) map to P2, filed in month five before the cartridge was shown to customers; claim 17 (a combination of temperature compensation with a hydration estimate) is nonprovisional-only. Counsel searches the period between P1 and the nonprovisional for hydration-estimate publications and finds a conference paper from month six. Claim 17 is redrafted to add a limitation the paper lacks.

Template 14: Inventor declaration packet

Purpose: collect accurate inventor declarations and confirm inventorship against the final claims. Owner: paralegal, with counsel available to answer questions. When to use: months ten to eleven, before the nonprovisional is filed.

To: [INVENTOR]
Re: U.S. patent application [TITLE], claiming provisional No. [NUMBER]

Enclosed are (1) the application as it will be filed, (2) a declaration
under 35 U.S.C. 115, and (3) [IF NEEDED] a confirmatory assignment.

Please:
- Read the application, including the claims.
- Confirm your full legal name and residence: [AS ON FILE].
- Tell us if you believe anyone else contributed to the ideas in any
  claim, or if you did not contribute to any claim.
- Tell us of any publications, products, sales, or other information you
  know of that may be material to patentability. You have a duty of
  candor to the Patent Office.
- Sign and return the declaration by [DATE].

Questions: [COUNSEL NAME, PHONE, EMAIL]

Drafting commentary. The declaration is required by 35 U.S.C. § 115 and 37 C.F.R. § 1.63; it may be filed after the application with an application data sheet, but collecting it now avoids chasing departed inventors later. A substitute statement under § 1.64 is available when an inventor is deceased, legally incapacitated, cannot be found, or refuses. The duty of candor under 37 C.F.R. § 1.56 runs to each inventor; asking about known art in the letter supports the information disclosure statement and helps avoid the inequitable conduct claims governed by Therasense, Inc. v. Becton, Dickinson & Co., 649 F.3d 1276 (Fed. Cir. 2011). The question about other contributors re-tests the map in Template 3 against the final claims.

Deadline tracker (single matter)

Practical notes

• Keep the forms with the matter file. Dated capture forms and audit worksheets corroborate conception and show the diligence that later disputes test.
• Do not overwrite. Save each version of the audit worksheet; the pre-filing version shows what the drafter knew.
• Watch the marking. "Patent pending" is true only while an application is pending, and false marking is actionable under 35 U.S.C. § 292 when done to deceive. See Patent Marking Compliance: A Practical Checklist.
• Pre-issuance notice has limits. A letter telling a competitor about a pending application does not create infringement liability, and provisionals never support § 154(d) royalties. See Managing Willfulness Risk After a Patent Notice Letter: A Practical Guide.

This document is general information, not legal advice for any particular situation. Adapt every template to the facts and current rules, and have a registered patent practitioner review filings.

Related Documents

Related Articles

• Provisional Patent Applications: What They Protect, What They Do Not, and How to Keep the Priority Date: the doctrine the templates implement.
• Prior Art Under the America Invents Act: Section 102, the On-Sale Bar, Public Use, and the One-Year Grace Period: the disclosure rules behind Template 1.
• Patent Ownership, Assignments, and Standing: Chain-of-Title Problems That Sink Cases: why Template 4 matters.
• Trade Secrets and Generative AI: Reasonable Measures, Prompt Leakage, and Vendor Terms: the AI clause in Template 1.

Related Guides

• Preparing and Filing a Provisional Patent Application: A Practical Guide: the steps in which each template is used.
• How to Prepare an Invention Disclosure for Your Patent Attorney: inventor preparation for Template 2.
• Building and Managing a Global Patent Portfolio: A Practical Guide: how the month-nine decision fits a portfolio.
• Managing Willfulness Risk After a Patent Notice Letter: A Practical Guide: the limits of pre-issuance notice.

Related Checklists

• Provisional Patent Application Checklist: A Practical Checklist: the task list these templates support.
• Preparing an Invention Disclosure: A Practical Checklist: materials to gather before capture.
• Patent Marking Compliance: A Practical Checklist: marking during and after the provisional year.
• International Patent Filing Checklist: A Practical Checklist: the foreign tasks at month twelve.

Related Toolkits

• Prior Art Toolkit: Search Protocols, Invalidity Charts, and On-Sale Bar Investigations: charts that pair with the priority map.
• Global Patent Portfolio Toolkit: Filing Calendars, National Phase Instructions, and Cost Models: calendars beyond month twelve.
• AI Confidentiality Toolkit: Acceptable Use Policies, Vendor Term Reviews, and Incident Playbooks: AI use policies for invention material.
• Brand Ownership Toolkit: Assignment Agreements, Founder IP Clauses, and Ownership Evidence Files: founder and contractor IP clauses.
• Trade Secret Protection Toolkit: Building and Defending a Confidentiality Program: the program for features kept secret.